Empirical metronidazole for patients with severe bacterial infection: protocol for a systematic review

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Acta Anaesthesiologica Scandinavica

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/aas.13101PMID 29520759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review

  2017cited by this paper
• Are anaerobes a major, underappreciated cause of necrotizing infections?

  2017cited by this paper
• Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik’s Cube of Clinical Microbiology?

  2017cited by this paper
• Clinical and Neuroradiological Spectrum of Metronidazole Induced Encephalopathy: Our Experience and the Review of Literature.

  2016cited by this paper
• Spectrum and treatment of anaerobic infections.

  2016influential reference
• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

  2015cited by this paper
• Published by John Wiley & Sons Ltd

  2015cited by this paper
• Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades.

  2015cited by this paper
• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

  2015cited by this paper
• Handling trial participants with missing outcome data when conducting a meta-analysis: a systematic survey of proposed approaches

  2015cited by this paper
• Interactions of metronidazole with other medicines: a brief review.

  2014influential reference
• Economic Impact of Redundant Antimicrobial Therapy in US Hospitals

  2014cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration

  2013cited by this paper
• Management of necrotizing skin and soft tissue infections

  2012cited by this paper
• Management of necrotizing skin and soft tissue infections.

  2012cited by this paper
• Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

  2011cited by this paper
• Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration

  2011cited by this paper
• Metronidazole is still the drug of choice for treatment of anaerobic infections.

  2010influential reference
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• The Epidemiology of Intra-Abdominal Flora in Critically Ill Patients with Secondary and Tertiary Abdominal Sepsis

  2009cited by this paper
• Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study.

  2009cited by this paper
• Effectiveness of meropenem for the treatment of aspiration pneumonia in elderly patients.

  2009cited by this paper
• Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.

  2008cited by this paper
• Grading quality of evidence and strength of recommendations

  2004influential reference
• What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

  2004cited by this paper
• Colonization and infection of the respiratory tract: What do we know?

  2004cited by this paper
• Microbiology of severe aspiration pneumonia in institutionalized elderly.

  2003cited by this paper
• Metronidazole. A therapeutic review and update.

  1997cited by this paper
• Clinical features and aerobic and anaerobic microbiological characteristics of cellulitis.

  1995cited by this paper
• Clinical and microbiological features of necrotizing fasciitis

  1995cited by this paper
• Overview of clinically important anaerobes.

  1995cited by this paper
• The bacteriology of aspiration pneumonia.

  1974cited by this paper
• [The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].

  1959cited by this paper

• Epidemiology and antibiotic susceptibility profiles of obligate anaerobes in a hospital of central Italy during a one-year (2019) survey.

  2022cites this paper
• Empirical metronidazole for patients with severe bacterial infection: A systematic review with meta‐analysis and trial sequential analysis

  2019cites this paper